R&D innovation and the value of cash in the biotech industry |
| |
Authors: | Bixia Xu |
| |
Institution: | School of Business & Economics, Wilfrid Laurier University, Waterloo, Ontario, Canada N2L 3C5 |
| |
Abstract: | This study investigates how the market pricing of an additional dollar of cash held by biotech firms is conditional upon the industry's typical performance, R&D innovation. Under the proposed R&D innovation regime, I find i) an additional dollar of cash is priced higher if held by a firm with higher R&D innovation; ii) the role of R&D innovation is asymmetric depending on whether R&D activities move the drug discovery and development forward or backward; and iii) R&D innovation also differentiates the association between investment opportunities and value of cash observed by prior studies. |
| |
Keywords: | Cash reserves R& D innovation Market pricing of cash reserves Investment opportunities |
本文献已被 ScienceDirect 等数据库收录! |
|